APA (7th ed.) Citation

N, B., G, A., LN, K., B, R., M, S., Z, Z., . . . GW, S. (2022). Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: The COAPT trial. European heart journal, 43(17), 1639. https://doi.org/10.1093/eurheartj/ehac026

Chicago Style (17th ed.) Citation

N, Beohar, et al. "Impact of Baseline Renal Dysfunction on Cardiac Outcomes and End-stage Renal Disease in Heart Failure Patients with Mitral Regurgitation: The COAPT Trial." European Heart Journal 43, no. 17 (2022): 1639. https://doi.org/10.1093/eurheartj/ehac026.

MLA (9th ed.) Citation

N, Beohar, et al. "Impact of Baseline Renal Dysfunction on Cardiac Outcomes and End-stage Renal Disease in Heart Failure Patients with Mitral Regurgitation: The COAPT Trial." European Heart Journal, vol. 43, no. 17, 2022, p. 1639, https://doi.org/10.1093/eurheartj/ehac026.